HomeLTRN • NASDAQ
add
Lantern Pharma Inc
Previous close
$5.46
Day range
$5.42 - $6.04
Year range
$2.38 - $11.99
Market cap
59.08M USD
Avg Volume
348.11K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 4.88M | 27.47% |
Net income | -4.19M | -23.80% |
Net profit margin | — | — |
Earnings per share | -0.38 | — |
EBITDA | -4.87M | -27.46% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 41.30M | -25.17% |
Total assets | 43.65M | -25.82% |
Total liabilities | 2.74M | -2.09% |
Total equity | 40.91M | — |
Shares outstanding | 10.74M | — |
Price to book | 1.43 | — |
Return on assets | -26.68% | — |
Return on capital | -28.09% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -4.19M | -23.80% |
Cash from operations | -3.39M | -26.85% |
Cash from investing | 256.18K | -57.51% |
Cash from financing | -500.00K | — |
Net change in cash | -3.63M | -76.74% |
Free cash flow | -1.86M | -18.84% |
About
Founded
2013
Headquarters
Website
Employees
21